Ministerio de Sanidad

Spain

Ministerio de Sanidad

Spain
SEARCH FILTERS
Time filter
Source Type

Olmos J.M.,Ministerio de Sanidad
Journal of Generic Medicines | Year: 2011

In Spain, the main goal of pharmaceutical provision is to provide access to all patients to the medicines they need in a timely and appropriate manner, in conformity with the sustainability of medium and long-term provision. These objectives of sustainability and effi ciency attach great importance to the promotion of generic medicines. We have been working to promote generic medicines for many years, but since we started later than many of our neighbouring countries, we have not achieved the same level of use. However, we have a reference price system that enables us to set a maximum fi nancing price for all medicines containing the same active ingredient and having the same route of administration once the innovator ' s patent protection has expired and a generic version has been launched. In the fi rst half of 2010, the generic medicines market experienced signifi cant growth in units, reaching a public market share of 26.02 per cent per prescription. In order to give them fresh impetus and continue working in this line of growth, a specifi c Plan has been adopted. This Plan emphasises the provision of information and education to citizens; the participation of community pharmacies in providing information to citizens and dispensing generic medicines; the provision of information and training to health professionals on their quality, safety and effi cacy; and the streamlining of the marketing authorisation procedure and decision-making process on their public fi nancing. © 2011 SAGE Publications.


PubMed | Hospital Clinic Of Barcelona Ciberes, Hospital Universitario Of Burgos Ciberes, Hospital San Pedro Of Alcantara Ciberes, Sociedad Espanola de Medicina de Trafico and 2 more.
Type: | Journal: Archivos de bronconeumologia | Year: 2016

Road traffic accidents are one of the main causes of death worldwide and are clearly associated with sleepiness. Individuals with undiagnosed sleep apnea-hypopnea syndrome (SAHS) are among the population with a high risk of experiencing sleepiness at the wheel and, consequently, road traffic accidents. Treatment with continuous positive airway pressure (CPAP) has been shown to reduce the risk of accidents among drivers with SAHS. For this reason, the European Union has included this disease in the psychological and physical criteria for obtaining or renewing a driving license. To comply with this European Directive, Spain has updated its driving laws accordingly. To facilitate the implementation of the new regulations, a group of experts from various medical societies and institutions has prepared these guidelines that include questionnaires to screen for SAHS, diagnostic and therapeutic criteria, and physicians report templates.


PubMed | Sociedad Espanola de Epidemiologia., Federacion de Asociaciones de Enfermeria Comunitaria y Atencion Primaria., Sociedad Espanola de Arteriosclerosis., Ministerio de Sanidad and 12 more.
Type: | Journal: Hipertension y riesgo vascular | Year: 2016

The VI European Guidelines for Cardiovascular Prevention recommend combining population and high-risk strategies with lifestyle changes as a cornerstone of prevention, and propose the SCORE function to quantify cardiovascular risk. The guidelines highlight disease specific interventions, and conditions as women, young people and ethnic minorities. Screening for subclinical atherosclerosis with noninvasive imaging techniques is not recommended. The guidelines distinguish four risk levels (very high, high, moderate and low) with therapeutic objectives for lipid control according to risk. Diabetes mellitus confers a high risk, except for subjects with type 2 diabetes with less than <10 years of evolution, without other risk factors or complications, or type 1 diabetes of short evolution without complications. The decision to start pharmacological treatment of arterial hypertension will depend on the blood pressure level and the cardiovascular risk, taking into account the lesion of target organs. The guidelines dont recommend antiplatelet drugs in primary prevention because of the increased bleeding risk. The low adherence to the medication requires simplified therapeutic regimes and to identify and combat its causes. The guidelines highlight the responsibility of health professionals to take an active role in advocating evidence-based interventions at the population level, and propose effective interventions, at individual and population level, to promote a healthy diet, the practice of physical activity, the cessation of smoking and the protection against alcohol abuse.


PubMed | Sociedad Espanola de Epidemiologia., Federacion de Asociaciones de Enfermeria Comunitaria y Atencion Primaria., Sociedad Espanola de Arteriosclerosis., Ministerio de Sanidad and 12 more.
Type: | Journal: Revista espanola de salud publica | Year: 2016

The VI European Guidelines for Cardiovascular Prevention recommend combining population and high-risk strategies with lifestyle changes as a cornerstone of prevention, and propose the SCORE function to quantify cardiovascular risk. The guidelines highlight disease specific interventions, and conditions as women, young people and ethnic minorities. Screening for subclinical atherosclerosis with noninvasive imaging techniques is not recommended. The guidelines distinguish four risk levels (very high, high, moderate and low) with therapeutic objectives for lipid control according to risk. Diabetes mellitus confers a high risk, except for subjects with type 2 diabetes with less than 10 years of evolution, without other risk factors or complications, or type 1 diabetes of short evolution without complications. The decision to start pharmacological treatment of arterial hypertension will depend on the blood pressure level and the cardiovascular risk, taking into account the lesion of target organs. The guidelines dont recommend antiplatelet drugs in primary prevention because of the increased bleeding risk. The low adherence to the medication requires simplified therapeutic regimes and to identify and combat its causes. The guidelines highlight the responsibility of health professionals to take an active role in advocating evidence-based interventions at the population level, and propose effective interventions, at individual and population level, to promote a healthy diet, the practice of physical activity, the cessation of smoking and the protection against alcohol abuse.


PubMed | University of La Laguna, Ministerio de Sanidad, University of Murcia, Hospital Universitario 12 Of Octubre Servicio Of Neonatologia and Hospital Universitario La Paz
Type: | Journal: Revista espanola de salud publica | Year: 2016

Breastfeeding for its multiple benefits is the best cost-effective health intervention and should be a public health priority. The aim of this study was to determine motivations and barriers perceived by mothers to initiate or to maintain breastfeeding.A cross-sectional, observational study was carried in 2013 out among 569 mothers resident in Spain, with children under the age of 2, who completed a structured questionnaire. A two-stage sampling, stratified by Autonomous Communities and non-probabilistic within each community was used.88% of the mothers were breastfeeding their children or had breastfed. At the time of the survey 66.6% had stopped breastfeeding, and the average age for weaning was 6.4 (SD 3.8) months. The main reason for stopping breastfeeding was maternal perceptions of insufficient milk supply (29%). The second reason was going back to work (18%). 67% of the mothers said that they made the decision to breastfeed on their own. The main disadvantages reported were: the difficulty to reconcile breastfeeding and work (43%), breastfeeding in public places (39%), more frequent nighttime awakenings (62%) and the reduced weight gain of the baby (29%). Going back to work was the main reason for choosing formula feeding (34%) and also for initiating partial breastfeeding (39%).The main disadvantages reported were: the difficulty to reconcile breastfeeding and work, breastfeeding in public places, more frequent nighttime awakenings and the reduced weight gain of the baby. Going back to work was the main reason for choosing formula feeding and also for initiating partial breastfeeding.


Grant
Agency: European Commission | Branch: FP7 | Program: CSA | Phase: ICT-2013.5.1 | Award Amount: 391.83K | Year: 2013

Motivated by the transatlantic eHealth Cooperation Roadmap, Trillium Bridge aims to bridge patient summary specifications in the EU and US to support interoperability for improved health and healthcare delivery, economic growth and innovation.\nWith an outstanding well-balanced consortium, Trillium Bridge leverages epSOS patient access and Meaningful Use/Transitions of Care use cases:\n Mobilizes people and resources creating a forum of collaboration and knowledge sharing\n Compares patient summary specifications and associated policies including eIdentification, privacy & security to select pilot use cases and complete a gap analysis\n Assembles interoperability assets to align structure and terminology (semantic mapping services for value sets published by the National Library of Medicine & epSOS, clinical document structures, testing and validation tools)\n Develops testing tools and validation reports from committed US providers and epSOS sites.\n Informs development of implementation guides and template libraries for patient summaries in liaison with Standards Development Organizations decreasing standards development costs\n Creates a feasibility analysis for patient and provider-mediated exchange of patient summaries.\nOnline social tools engage input from eHealth stakeholders at all project stages. Interoperability resources assembled for the eHealth industry to use push the envelope in interoperability and fostering transatlantic cooperation and business engagement.\nTrillium Bridge will join forces with support actions, projects and initiatives contributing to policy alignment and sustainability upholding safety, empowerment, and well-being for European and US citizens when abroad. Thus, Trillium Bridge brings concrete measurable interoperability results at the technical, semantic, organizational, and legal levels, building on major initiatives to advance eHealth innovation and contribute the triple win: quality care, sustainability and economic growth.


Objectives: To analyze changes in real per capita spending by age and sex from 1998 to 2008 in Spain, and to assess their effects on public healthcare expenditure projections. Methods: Age- and sex-related expenditure profiles in constant terms were estimated for the Spanish population for 3 distinct years (1998, 2003 and 2008) by using data from hospital records and several National Health Surveys. These profiles were used to compare actual healthcare expenditure for 2003 and 2008 with the projections obtained by considering 1998 as the base year and by applying the methodology used by the Working Group on Aging of the European Union. Results: The average annual growth rate of real per capita spending per person from 1998 to 2008 was 2.79%, which was higher than the GDP per capita growth rate (1.90%), basically due to its high rate of increase in the second half of the decade. From 1998 to 2008, per capita healthcare expenditure increased in most age groups, particularly in the groups aged 45-49 years, 60-64 years and 75 years and older. Projections of per capita expenditure in constant terms covered the real value observed for 2003, but were below the real value for 2008. Conclusions: Changes in the quantity and quality of healthcare services consumed by each person are an important factor in changes in healthcare expenditure and must be included in spending projections. © 2012 SESPAS.


PubMed | Conselleria de Sanitat, Agencia de Salut Publica de Catalonia, Institute Salud Carlos III, Conselleria de Sanidade de Galicia and 2 more.
Type: Journal Article | Journal: Gaceta sanitaria | Year: 2016

At present, epidemiological surveillance in Spain remains focused on the communicable diseases included in the list of notifiable diseases. However, there has been a change in epidemiological pattern that predominated until the last few decades of the twentieth century. Infectious diseases, which used to be the leading causes of morbidity and mortality, have given way to a predominance of chronic diseases. In this regard, progress has been made in the drafting and adoption of specific legal regulations on public health monitoring. However, Spain has yet to develop this legislation which, among other elements, includes the mandate to organize the surveillance of non-communicable diseases in Spain. This article aims to describe some points that should be considered in the development of a national surveillance system linked to existing strategies for the prevention and control of chronic diseases.


PubMed | Ministerio de Sanidad, Center Destudis Epidemiologics Sobre Les Infeccions Of Transmissio Sexual da Of Catalonia Ceeiscat, Autonomous University of Barcelona and CIBER ISCIII
Type: Journal Article | Journal: Medicina clinica | Year: 2015

To describe the pattern of drug use among men who have sex with men (MSM) living in Spain and its association with sexual risk practices.The European MSM Internet Survey was implemented in 2010 in 38 European countries on websites for MSM and collected data on sociodemographics, sexual behavior, and other sexual health variables. The association between unprotected anal intercourse (UAI) with casual partners and drug consumption was evaluated using multivariate logistic regression models.Among the 13,111 participants, most consumed drugs were cannabis (30.1%), popper (28.4%) and cocaine (18.7%). The risk of UAI with casual partners was 1.5 among those who had used drugs in relation to the other participants. The proportion of MSM who had injected drugs at least once in life was 2.5%, and 1.4% in the last 12 months. The prevalence of UAI with casual partners (53.4%), human immunodeficiency virus (HIV) (23%), hepatitis C (8.2%) and sexually transmitted infections (STI) (15.8%) was higher in MSM injectors related to those who had not used injected drugs (P<.05).The results of this study confirm a high prevalence of drug use in MSM and their relationship to sexual risk behavior. Although the use of injected drugs in MSM is a minority, this group reported a higher level of sexual risk behaviors, self-reported HIV, hepatitis C and other STI.

Loading Ministerio de Sanidad collaborators
Loading Ministerio de Sanidad collaborators